InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,615.35
(
0.55%
)
US TECH 100
19,804.00
(
0.64%
)
Dow Jones
40,000.90
(
0.62%
)
Brent Oil
84.57
(
0.00%
)
Bitcoin
60,059.43
(
1.39%
)
Post# of 30387
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

bocxman

Send PM Follow Ignore
Followers 2
Posts 1054
Boards Moderated 0
Alias Born 03/03/2005

bocxman

Re: Kag post# 3861

Thursday, 05/25/2006 3:38:37 PM

Thursday, May 25, 2006 3:38:37 PM

Post# of 30387
kag, read the white paper again that BOCX published in response to the SEC's questioning of their (lung cancer?) data. the paper discusses the cutoff values they use for specificity. while it would be great for the "personalizaton" application if individuals had constant levels of RECAF, it has no bearing on whether or not RECAF will work as a general diagnostic tool. this is because there are clearly levels of RECAF which are abnormal across all individuals (thus the specificity cutoff points).

thoughts?

DISCLAIMER: NEVER ASSUME INFO ON MESSAGE BOARDS TO BE ACCURATE. ALWAYS DO YOUR OWN DUE DILIGENCE. DON'T BUY STOCK BASED ON THIS POST OR ANY OTHER POST. I OWN A LONG POSITION IN THIS STOCK AND THEREFORE I AM BIASED.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up